Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ROBERT ATMAR and SASIREKHA RAMANI.
ROBERT ATMAR
Connection Strength
7.072
SASIREKHA RAMANI
  1. Lack of Detection of Norwalk Virus in Saliva Samples From a Controlled Human Infection Model. Open Forum Infect Dis. 2024 Nov; 11(11):ofae652.
    View in: PubMed
    Score: 0.996
  2. INTRA- AND INTER-HOST EVOLUTION OF HUMAN NOROVIRUS IN HEALTHY ADULTS. bioRxiv. 2024 Sep 05.
    View in: PubMed
    Score: 0.985
  3. Birth Cohort Studies: Toward Understanding Protective Immunity to Human Noroviruses. Clin Infect Dis. 2021 01 27; 72(2):230-232.
    View in: PubMed
    Score: 0.767
  4. B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol. 2017 May; 24(5).
    View in: PubMed
    Score: 0.592
  5. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go? PLoS Pathog. 2016 04; 12(4):e1005334.
    View in: PubMed
    Score: 0.552
  6. Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis. 2015 Aug 01; 212(3):397-405.
    View in: PubMed
    Score: 0.506
  7. GI.1 Norovirus Neutralizing Antibody Levels Are Correlated with GI.1 Histo-blood Group Antigen-Blocking Antibody Levels. J Infect Dis. 2024 Jun 12.
    View in: PubMed
    Score: 0.242
  8. Divergent responses of human intestinal organoid monolayers using commercial in vitro cytotoxicity assays. PLoS One. 2024; 19(6):e0304526.
    View in: PubMed
    Score: 0.242
  9. 2'-Fucosyllactose Inhibits Human Norovirus Replication in Human Intestinal Enteroids. bioRxiv. 2024 May 30.
    View in: PubMed
    Score: 0.242
  10. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. J Infect Dis. 2024 May 15; 229(5):1402-1407.
    View in: PubMed
    Score: 0.241
  11. Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection. J Infect Dis. 2020 02 18; 221(5):739-743.
    View in: PubMed
    Score: 0.180
  12. Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges. Viruses. 2019 07 11; 11(7).
    View in: PubMed
    Score: 0.172
  13. Human noroviruses: recent advances in a 50-year history. Curr Opin Infect Dis. 2018 10; 31(5):422-432.
    View in: PubMed
    Score: 0.163
  14. Prospects and Challenges in the Development of a Norovirus Vaccine. Clin Ther. 2017 Aug; 39(8):1537-1549.
    View in: PubMed
    Score: 0.150
  15. Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol. 2014 Jan; 30(1):25-33.
    View in: PubMed
    Score: 0.117
  16. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis. 2014 Apr 01; 209(7):1016-22.
    View in: PubMed
    Score: 0.117
  17. Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 Nov 21; 9(11):e0044824.
    View in: PubMed
    Score: 0.062
  18. Insights into Human Norovirus Cultivation in Human Intestinal Enteroids. bioRxiv. 2024 Sep 19.
    View in: PubMed
    Score: 0.062
  19. Complete Genomic Characterization of Global Pathogens, Respiratory Syncytial Virus (RSV), and Human Norovirus (HuNoV) Using Probe-based Capture Enrichment. bioRxiv. 2024 Sep 16.
    View in: PubMed
    Score: 0.062
  20. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0063623.
    View in: PubMed
    Score: 0.058
  21. A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide. bioRxiv. 2023 May 23.
    View in: PubMed
    Score: 0.056
  22. Norovirus Protease Structure and Antivirals Development. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.050
  23. Glycan Recognition in Human Norovirus Infections. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.050
  24. Norovirus in Cancer Patients: A Review. Open Forum Infect Dis. 2021 Jun; 8(6):ofab126.
    View in: PubMed
    Score: 0.048
  25. New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal Enteroids. mSphere. 2021 01 27; 6(1).
    View in: PubMed
    Score: 0.048
  26. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 09 22; 117(38):23782-23793.
    View in: PubMed
    Score: 0.047
  27. Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection. mBio. 2020 03 17; 11(2).
    View in: PubMed
    Score: 0.045
  28. Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 01 21; 117(3):1700-1710.
    View in: PubMed
    Score: 0.045
  29. Glycan recognition in globally dominant human rotaviruses. Nat Commun. 2018 07 06; 9(1):2631.
    View in: PubMed
    Score: 0.040
  30. Structural features of glycan recognition among viral pathogens. Curr Opin Struct Biol. 2017 06; 44:211-218.
    View in: PubMed
    Score: 0.037
  31. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016 09 23; 353(6306):1387-1393.
    View in: PubMed
    Score: 0.035
  32. Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol. 2014 Aug; 7:119-27.
    View in: PubMed
    Score: 0.031
  33. Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med. 2014 Jan-Feb; 21(1):6-11.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.